1.

CRISPR-Cas9: what is beyond cancer immunotherapy?

Pages 1-11
Alya R. Elsergany; Omar Ahmed Abualata
2.

Immunohistochemical Study of 5-Methylthioadenosine Phosphorylase (MTAP) and Epithelial Membrane Antigen (EMA) in Differentiating Epithelioid Pleural Mesothelioma from Reactive Mesothelial Hyperplasia

Pages 13-23
Nehal Kamel Hussien; Mohamed M Shareef; Yomna Zamzam; Asmaa Mustafa Eid
3.

Using network analysis and machine learning to identify genes implicated in Spinal Muscular Atrophy

Pages 25-39
Eslam Mahmoud Ibrahim Imam Nofal; Elsayed Elsayed Hafez; Amira Yassein Mohamed Haikal; Mostafa Abdelkhalik Elhosseini
4.

The prognostic significance of Minichromosome maintenance protein 2 (MCM2) and Trans-glutaminase 2 (TGM2) in Endometrial carcinoma: immunohistochemical and serological study

Pages 41-54
Nehal Abd El-Ghaffar Heabah; Sara A. Darwish; Rasha A. Elkholy; Asmaa Elsayed Bedeer
5.

Evaluation of the clinicopathological significance of E-Cadherin and Ki 67 immuno-expression in triple negative breast cancer

Pages 55-67
Eman Basiouny Esmail; Mohammed Ali El-rashidy; Heba Abd El-hai Mashhour; Hend Salah Abo-Safia
6.

Effect of thyroglobulin level before ablative Radioactive Iodine on response and survival among patients with Differentiated Thyroid Carcinoma

Pages 69-77
Ahmad A Abdelrahman